TVTX
Travere Therapeutics, Inc. Common Stock#65 · 2024BreakoutBYearly return
+82%
Peak return
+113%
Max drawdown
-50%
ADR (20 days)
+4.1%
Base
24 days / -39.6%
Prior run
+130%
Breakout volume
2.3x
Pivot
$15.61
Catalyst Relative Staerke/Technik2024-10-07TVTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Travere Therapeutics, Inc. and Encourages Investors to Contact the FirmGlobeNewswire Inc.
Kein klarer externer Katalysator in der News-Abdeckung; technische relative Staerke dominiert.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare TVTX with the current market directly.